Trial Profile
Phase 2 Study of Dose-Intense Temozolomide in Recurrent Glioblastoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 May 2014
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma; Gliosarcoma
- Focus Therapeutic Use
- 13 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Mar 2013 Planned end date changed from 1 Aug 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.
- 21 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.